Mozambique denies India 5 more coal concessions
Mozambique on Monday turned down a request by the Indian government for five coal concessions, saying the Asian giant should first develop its two existing blocks in the southern African nation.
Pope calls on Pakistan to repeal blasphemy law
Pope Benedict called on Monday for Pakistan to repeal its anti-blasphemy law, days after a senior Pakistani politician who opposed the legislation was assassinated by his own bodyguard.
CCCL subsidiary signs power purchase agreement with NTPC
Consolidated Construction Consortium subsidiary has signed power purchase agreement with NTPC.
M&M Financial JV with De Lage Landen Financial
M&M Financial has entered into a JV with De Lage Landen Financial Services Inc wholly-owned subsidiary of the Rabobank Group.
Sun Pharma Dec qtr PAT seen up 19.7% at Rs 394.2cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Sun Pharma December quarter sales are expected to go up by 55.3% to Rs 1585.9 crore, Year-on-Year, (Y-o-Y) basis.
RPP Infra Project board to consider interim dividend
RPP Infra Project board to consider interim dividend in the meeting of the Board of Directors of the Company will be held on January 18, 2011.
Ashoka Buildcon receives letter from NHAI
Ashoka Buildcon has recieved letter from NHAI for the Six Lane Highway project at a total cost of Rs 694 crore.
Ranbaxy Dec qtr PAT seen up 193% at Rs 319.9cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Ranbaxy December quarter sales are expected to go up by 4.7% to Rs 2361.3 crore, Year-on-Year, (Y-o-Y) basis.
Cipla Dec qtr PAT seen down 6.9% at Rs 287.5cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Cipla December quarter sales are expected to go up by 11.8% to Rs 1607.5 crore, Year-on-Year, (Y-o-Y) basis.
Hold Hero Honda Motors; target of Rs 1988: KRChoksey
KRChoksey has maintained hold rating on Hero Honda Motors with a target of Rs 1988 in its January 10, 2011 research report.
Lupin Dec qtr PAT seen up 29.8% at Rs 208.5cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Lupin December quarter sales are expected to go up by 19.3% to Rs 1515.9 crore, Year-on-Year, (Y-o-Y) basis.
Torrent Pharma Dec qtr PAT seen down at Rs 82.3cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Torrent Pharma December quarter sales are expected to go up by 19.3% to Rs 572.5 crore, Year-on-Year, (Y-o-Y) basis.
Accumulate GSFC; target of Rs 357: Asit C. Mehta
Asit C. Mehta is bullish on Gujarat State Fertilizers & Chemicals (GSFC) and has recommended accumulate rating on the stock with a target of Rs 357 in its January 10, 2011 research report.
Dr Reddy Dec qtr PAT seen up 62.4% at Rs 387.9cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Dr Reddy December quarter sales are expected to go up by 20.3% to Rs 2081.2 crore, Year-on-Year, (Y-o-Y) basis.
Pfizer Dec qtr PAT seen up 17.3% at Rs 49.9cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Pfizer December quarter sales are expected to go up by 11.1% to Rs 227.5 crore, Year-on-Year, (Y-o-Y) basis.
GlaxoSmithKline Dec qtr PAT seen up at Rs 119.9cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, GlaxoSmithKline December quarter sales are expected to go up by 14.3% to Rs 514.3 crore, Year-on-Year, (Y-o-Y) basis.
Government of India announce the sale of three dated securities for ` 11,000 crore on January 14, 2011
Government of India announce the sale of three dated securities for ` 11,000 crore on January 14, 2011
DuPont to acquire Danisco for $6.3bn
Chemicals major DuPont is looking at acquiring Denmark's enzyme and specialty food ingredients maker Danisco for USD 6.3 billion.
Buy Indraprastha Gas; target of Rs 399: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Indraprastha Gas (IGL) and has recommended buy rating on the stock with a target of Rs 399, in its January 10, 2011 research report.
Unichem Labs Dec qtr PAT seen down at Rs 26.9cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Unichem Labs December quarter sales are expected to go up by 11.7% to Rs 192.9 crore, Year-on-Year, (Y-o-Y) basis.
ACC Dec qtr PAT seen down by 34% at Rs 186 cr: Angel
Angel Broking has come out with its earning estimates on Cement sector for the quarter ended December 2010. According to the research firm, ACC quarter sales are expected to go down by 3.3% at Rs 1919 crore, Year-on-Year, (YoY) basis.
RBI Announces OMO Purchase of Government Securities for ` 12,000 crore on January 12, 2011
RBI Announces OMO Purchase of Government Securities for ` 12,000 crore on January 12, 2011
Iran Air crash toll rises to 77, eight critical
At least 77 people were killed in Sunday's passenger plane crash in northwestern Iran, the official IRNA news agency reported on Monday.
M&M Finance to form JV with Rabobank Group unit
Mahindra & Mahindra Financial Services said on Monday it has entered into a joint venture with De Lage Landen Financial Services Inc, a wholly-owned subsidiary of the Rabobank Group.
Panacea Biotech Dec qtr PAT seen up at Rs 26.7cr: Emkay
Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Panacea Biotec December quarter sales are expected to go up by 24.4% to Rs 287.8 crore, Year-on-Year, (Y-o-Y) basis.
